Please select a Capability in order to start your service request.
Franklin Lakes, NJ (May 15, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences:
Bank of America Merrill Lynch 2017 Healthcare Conference
May 17, 2017
11:40 a.m. EDT
Jefferies 2017 Global Healthcare Conference
June 8, 2017
9:00 a.m. EDT
Goldman Sachs 38th Annual Global Healthcare Conference
June 13, 2017
11:40 a.m. EDT
Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days after each conference.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.